Literature DB >> 287020

Induction of rat sarcomas in rats treated with antithymocyte sera after transplantation of human cancer cells.

R J Huebner, D C Fish, D Djurickovic, R W Trimmer, A L Bare, R M Bare, G T Smith.   

Abstract

Human cancer cells that had had high (greater than 160) tissue culture passages, when transplanted into antithymocyte-treated F344 newborn rats, caused induction of rat sarcomas in the rats within 2 or 3 subcultures, whereas human cancer cells with low (5-33) passages in vitro did not cause overt induction of rat sarcomas until after 5-10 subtransplantations. Because oncornavirus activity was not detected in either rat or human tumors, it is suggested that transforming sequences located on the human tumor cells may have been transferred to supporting rat reticulum cells in close contact with the human cancer cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 287020      PMCID: PMC383477          DOI: 10.1073/pnas.76.4.1793

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  4 in total

1.  In vitro isolation of stable rat sarcoma viruses.

Authors:  S Rasheed; M B Gardner; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  Cultivation in vitro of cells derived from a human rhabdomyosarcoma.

Authors:  R M McAllister; J Melnyk; J Z Finkelstein; E C Adams; M B Gardner
Journal:  Cancer       Date:  1969-09       Impact factor: 6.860

3.  Cultivation in vitro of cells derived from a human osteosarcoma.

Authors:  R M McAllister; M B Gardner; A E Greene; C Bradt; W W Nichols; B H Landing
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

4.  Characterization of human cells transformed in vitro by N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  J S Rhim; D L Putman; P Arnstein; R J Huebner; R M McAllister
Journal:  Int J Cancer       Date:  1977-04-15       Impact factor: 7.396

  4 in total
  8 in total

1.  Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells.

Authors:  S Pulciani; E Santos; A V Lauver; L K Long; K C Robbins; M Barbacid
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

2.  In vivo horizontal oncogenesis by a human tumor in nude mice.

Authors:  D M Goldenberg; R A Pavia
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

3.  Induction of sarcomas in athymic mice.

Authors:  G M Beattie; A F Knowles; F C Jensen; S M Baird; N O Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

4.  In vivo induction of neoplastic growth in nude mouse connective tissue adjacent to xenografted human tumors.

Authors:  H J Staab; H Heilbronner; M Schrader; F A Anderer
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  Enhanced tumorigenicity of cloned UV-regressor tumor lines following selected in vivo and in vitro manipulations.

Authors:  M K Schmitt; L K Roberts; L C Gahring; R A Daynes
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

6.  In-vivo fusion of human cancer and hamster stromal cells permanently transduces and transcribes human DNA.

Authors:  David M Goldenberg; Robert J Rooney; Meiyu Loo; Donglin Liu; Chien-Hsing Chang
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

7.  Alterations of mouse proto-oncogenes in sarcomas induced after transplantation of human tumors in athymic nude mice.

Authors:  Y Yuasa; H Yamazaki; K Maruo; Y Ueyama; M Shibuya; N Tamaoki
Journal:  Jpn J Cancer Res       Date:  1990-04

Review 8.  Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.

Authors:  Shengming Zhu; Jiangang Wang; Lucas Zellmer; Ningzhi Xu; Mei Liu; Yun Hu; Hong Ma; Fei Deng; Wenxiu Yang; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2022-07-04       Impact factor: 4.478

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.